title: Redefining the role of lymphocytes in gastroesophageal reflux disease and eosinophilic esophagitis.
abstract: Eosinophilic esophagitis (EoE) and reflux esophagitis (RE) overlap clinically and histologically. RE is characterized by epithelial infiltration with small numbers of neutrophils and eosinophils, EoE by a prominent eosinophilic infiltrate. Lymphocytic esophagitis (LE), a new entity characterized by peripapillary lymphocytosis, questions the role lymphocytes play in esophageal inflammation. We test the hypothesis that lymphocyte infiltration in RE differs from EoE. One blinded pathologist read esophageal biopsies from 39 RE and 39 EoE patients. Both groups demonstrated significant numbers of lymphocytes (RE 22.7 +/- 2.2/HPF, EoE 19.8 +/- 1.8/HPF). Eosinophils/HPF in RE and EoE were 2.8 +/- 0.7 and 74.9 +/- 8.2, respectively (P < 0.001). Neutrophils were uncommon in RE (0.26 +/- 0.16/HPF) and EoE (0.09 +/- 0.04; P = 0.07). Eight of the 39 RE specimens had >or=50 lymphocytes in >or=1 HPF. Two were consistent with LE. There was an inverse correlation between numbers of eosinophils and lymphocytes in EoE (R = -0.47; P = 0.002), and no correlation between them in RE (R = 0.18; P = 0.36). The patients with EoE who used antireflux medications had fewer lymphocytes (16.3 +/- 1.3 vs 22.2 +/- 2.3/HPF; P = 0.030) and eosinophils (55.6 +/- 5.2 vs 76.0 +/- 8.7/HPF; P = 0.042) than those who did not. The pathological role of lymphocytes in RE and EoE may be underestimated. Our observation that 5% of the RE specimens meet histopathological criteria for LE potentially blurs the line between these entities. The observation that eosinophil counts are lower in EoE when antireflux meds are used supports the notion that reflux plays a role in the clinical expression of EoE.
authors.affiliation: GI Motility Program, Division of Gastroenterology, Cedars-Sinai Medical Center, Los Angeles, California 90048, USA.
authors.forename: B
authors.initials: B
authors.lastname: Basseri
authors.forename: M
authors.initials: M
authors.lastname: Levy
authors.forename: H L
authors.initials: HL
authors.lastname: Wang
authors.forename: O A
authors.initials: OA
authors.lastname: Shaye
authors.forename: M
authors.initials: M
authors.lastname: Pimentel
authors.forename: E E
authors.initials: EE
authors.lastname: Soffer
authors.forename: J L
authors.initials: JL
authors.lastname: Conklin
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D004802:Eosinophilia / Q000276:immunology* / Q000473:pathology; D004941:Esophagitis / Q000276:immunology* / Q000473:pathology; D005260:Female; D005764:Gastroesophageal Reflux / Q000188:drug therapy / Q000276:immunology* / Q000473:pathology; D006801:Humans; D018655:Lymphocyte Count; D008214:Lymphocytes / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D009504:Neutrophils; D054328:Proton Pump Inhibitors / Q000627:therapeutic use; D012189:Retrospective Studies; D055815:Young Adult
chemical_list: D054328:Proton Pump Inhibitors